You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the QSYMIA (phentermine hydrochloride; topiramate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR QSYMIA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for QSYMIA

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00796367 ↗	A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)	Completed	Medpace, Inc.	Phase 3	2008-12-01	The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521 compared to placebo for the treatment of overweight and obesity in adults who have completed study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol OB-303 (NCT00553787).
NCT00796367 ↗	A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)	Completed	VIVUS, Inc.	Phase 3	2008-12-01	The purpose of this study is to evaluate the long-term safety and efficacy of VI-0521 compared to placebo for the treatment of overweight and obesity in adults who have completed study OB-303 (NCT00553787) at selected study sites. This is an extension study of protocol OB-303 (NCT00553787).
NCT01834404 ↗	Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 4	2013-04-01	Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric emptying, gastric accommodation, satiety, and satiation in obese participants.
NCT01834404 ↗	Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients	Completed	Mayo Clinic	Phase 4	2013-04-01	Our overall goal is to determine the effect of Phentermine and Topiramate ER on gastric emptying, gastric accommodation, satiety, and satiation in obese participants.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for QSYMIA

Condition Name

Chart
Table

Condition Name for QSYMIA
Intervention	Trials
Obesity	12
Binge Eating Disorder	2
Adolescent Overweight	1
Weight Loss	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for QSYMIA
Intervention	Trials
Obesity	10
Overweight	5
Feeding and Eating Disorders	2
Pediatric Obesity	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for QSYMIA

Trials by Country

Map
Table

Trials by Country for QSYMIA
Location	Trials
United States	13
Korea, Republic of	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for QSYMIA
Location	Trials
Minnesota	5
Ohio	3
Oklahoma	1
Louisiana	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for QSYMIA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for QSYMIA
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	3
Phase 2	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for QSYMIA
Clinical Trial Phase	Trials
Completed	8
Recruiting	4
Not yet recruiting	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for QSYMIA

Sponsor Name

Chart
Table

Sponsor Name for QSYMIA
Sponsor	Trials
VIVUS, Inc.	4
Mayo Clinic	3
University of Minnesota	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for QSYMIA
Sponsor	Trials
Other	12
Industry	9
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.